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The emergence of small open reading frame (sORF)-encoded peptides (SEPs) is rapidly
expanding the known proteome at the lower end of the size distribution. Here, we show that
the mitochondrial proteome, particularly the respiratory chain, is enriched for small proteins.
Using a prediction and validation pipeline for SEPs, we report the discovery of 16 endogenous
nuclear encoded, mitochondrial-localized SEPs (mito-SEPs). Through functional prediction,
proteomics, metabolomics and metabolic flux modeling, we demonstrate that BRAWNIN, a
71 a.a. peptide encoded by C12orf73, is essential for respiratory chain complex III (CIII)
assembly. In human cells, BRAWNIN is induced by the energy-sensing AMPK pathway, and
its depletion impairs mitochondrial ATP production. In zebrafish, Brawnin deletion causes
complete CIII loss, resulting in severe growth retardation, lactic acidosis and early death. Our
findings demonstrate that BRAWNIN is essential for vertebrate oxidative phosphorylation.
We propose that mito-SEPs are an untapped resource for essential regulators of oxidative
metabolism.
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The size and complexity of the human proteome is con-stantly evolving, ranging from genome-based estimationsof 20,000 canonical proteins to over 70,000 if one considers
protein variants (Uniprot, 2020). With the advent of ribosome
profiling, the question of the size of the human proteome
must once again be revisited. By detecting RNA translation at
sub-codon resolution1, ribosome profiling has unexpectedly
uncovered thousands of coding regions hitherto thought to be
translationally silent2. In particular, small open reading frames
(sORFs) nestled within long non-coding RNAs (lncRNAs),
pseudogenes, intergenic transcripts or upstream of known ORFs
(uORFs) that were previously not considered to be functional
have now been shown to encode bona fide peptides2–5. Evidence
accumulating within the last decade point to the widespread
prevalence of sORF-encoded peptides, or SEPs, and have spurred
multiple independent efforts to discover and catalog them6–8.
From a biological point of view, the SEP mini-proteome is a rich
repository of unexplored gene functions. However, unlike the
high throughput techniques that enabled their discovery, func-
tional de-orphanization of SEPs remains a resource-intensive
endeavor that relies on fundamental approaches in experimental
biology. To date, SEPs have been implicated in diverse functions
ranging from cardiovascular and placental development,
mTORC1 activation, calcium signaling, mRNA de-capping to
membrane fusion, and oocyte fertilization9–15. However, whether
SEPs have programmatic functions enabled by their small size
remains an open question. To this end, we asked if SEPs were
particularly enriched in subcellular locations that would provide
instructive cues for their functional characterization.
Results
Mitochondria proteome is enriched in SEPs. To this point, we
observed that the mitochondria proteome, particularly at the
inner mitochondrial membrane (IMM) (cataloged in Mitocarta
2.016) is enriched for proteins smaller than 100 a.a. i.e. SEPs (p-
value= 2.2×10−16) (Fig. 1a–c), and speculated that mitochondria
are a hotspot for SEP function. To uncover novel mitochondria-
targeted SEPs (mito-SEPs) from the human SEP peptidome7,
2343 high-quality human SEPs encoded by annotated short-
coding sequence (CDS) genes, lncRNAs, uORFs, and intergenic
ORFs were selected for test of mitochondrial localization (Fig. 1d,
details in Supplementary Note 1). We first employed a three-
prong strategy that identified a candidate mito-SEP on the basis
of a mitochondrial gene expression signature (Supplementary
Fig. 1a); a mitochondrial targeting protein domain (Supplemen-
tary Fig. 1b) or empirical detection of the SEP in mass spectro-
metric data of purified mitochondria (details in Supplementary
Note 1). Altogether, our mito-SEP discovery pipeline identified
173 candidates (Fig. 1d and Supplementary Data 1), including
2 positive controls MKKS uORF1 and uORF217. HA-tagged
mito-SEP candidates were experimentally validated by immuno-
fluorescence of transfected HeLa cells (Fig. 1e). In total, we suc-
cessfully validated protein expression for 88/173 sORFs
(Supplementary Data 1), defined as the ability of the ORF to
generate a peptide with sufficient stability to enable detection
(Supplementary Fig. 1c–e). Of these, 23% (20/88) of successfully
expressed peptides displayed unambiguous mitochondrial locali-
zation including the MKKS uORFs (Fig. 1e). Among the positive
candidates were MTLN/MOXI and MIEF1 uORF which were
subsequently independently discovered to have critical roles in
mitochondria metabolism and mtDNA translation18–21, provid-
ing proof for the robustness of our pipeline. All in all, our screen
identified 16 bona fide mito-SEPs of unknown function (MSUF)
encoded by uORFs, lincRNAs and short CDSs (Fig. 1e and
Table 1).
Preferential use of SEPs in respiratory complexes. Mitochon-
dria are the principal sites of energy conversion where ATP is
generated through the process of oxidative phosphorylation
(OXPHOS). Defects in OXPHOS are responsible for many
inherited mitochondrial diseases and manifest in aging and
metabolic disorders such as diabetes, heart disease, and cancer22.
Notably, 63.5% (40/63) of known mitochondrial low molecular
weight (MW) proteins function as assembly factors or core sub-
units of respiratory chain (RC) complexes that carry out
OXPHOS (Supplementary Fig. 1f). RC complexes are vice versa
enriched for low MW proteins (Supplementary Fig. 1g). Of the 16
mito-SEPs, the expression of 8 correlated with respiratory chain
and electron transport function above the 90th percentile
(Fig. 1f), suggesting that half of them participate directly or
indirectly in oxidative phosphorylation.
BRAWNIN resides in the IMM and responds to AMPK. We
selected a mito-SEP encoded by the C12orf73 gene, which we re-
named BRAWNIN (BR) (Fig. 2a and Supplementary Fig. 2a), for
further characterization because its stable overexpression in
U87MG significantly enhanced OXPHOS (Supplementary
Fig. 2b). The BR peptide is conserved in vertebrates (Fig. 2b) but
not in yeast and nematodes. Although ribosome profiling detec-
ted 2 plausible BR peptides arising from alternative splicing
(Fig. 2a and Supplementary Fig. 2c), we confirmed that only the
cDNA of the long isoform (P1) produced a stable 8-kDa peptide,
while the short isoform (P2) was remarkably less stable even
when over-expressed (Supplementary Fig. 2d). Endogenous BR
was detected by western blotting with a custom α-BR antibody in
HEK293T and HeLa cell lysates (Fig. 2c) and can be depleted by
siRNAs targeting the BR transcript (Fig. 2d, e). Endogenous BR is
enriched in mitochondria-rich fractions (Fig. 2f), and co-localized
with Mitotracker in both HeLa and HEK293T (Fig. 2g, h).
Altogether, these data confirm that BR is a nuclear-encoded
peptide that is imported into the mitochondria. In vivo, Br can be
detected in mouse skeletal muscle where it co-localizes with
matrix marker Citrate Synthase (CS) and with a mitochondria-
targeted GFP transgene mito-Dendra223 (Fig. 2i, j). BR is also
detectable in human cardiac and skeletal muscle (Supplementary
Fig. 2e) where it displays a staining pattern characteristic of the
mitochondria network. Moreover, BR protein abundance in
mouse tissues correlated well with that of mitochondrial
respiratory chain proteins, being high in brown adipose, cardiac
and skeletal muscle but virtually undetectable in white adipose
tissue (Supplementary Fig. 2f). Together, these results establish
that BR is a bona fide endogenous mito-SEP both in vitro and
in vivo.
Because mitochondria are highly compartmentalized, the
molecular function of a protein determines its sub-
mitochondrial location and vice versa24. We first established that
BR is membrane-bound by sodium carbonate extraction (Fig. 2k).
Next, using differential detergent extraction, we determined that
BR resides in the IMM and not in the outer mitochondrial
membrane (OMM) (Fig. 2l). Proteinase K protection assays
further suggest that the C-terminus of BR faces the intermem-
brane space (IMS) (Fig. 2m). In contrast to its clear mitochondrial
localization, human BR lacks a classical mitochondrial targeting
sequence (MTS); its N-terminus is instead predicted to function
as a secretory signal peptide by SignalP25. Indeed, when
overexpressed, BR can be detected in the supernatant (Supple-
mentary Fig. 2g). However, this may not represent bona fide
secretion as it cannot be inhibited by brefeldin A. Hence, the N-
terminal “signal peptide”, which is not cleaved (Supplementary
Fig. 2h), functions as a mitochondrial targeting single-pass
transmembrane domain (TMD) to anchor endogenous BR into
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the IMM. Consistent with this, BR-P2, which contains the full
TMD of BR-P1, is similarly targeted to the mitochondria despite
its relative instability (Supplementary Fig. 2i). Removal of the
predicted TMD from BR (BRΔN25), while causing its near
complete destabilization (Supplementary Fig. 2j), targets BRΔN25
to the cytosol instead of the mitochondria (Supplementary
Fig. 2k).
Proteins in the IMM participate in a wide variety of processes,
most commonly OXPHOS, calcium import, and the transport of
proteins and metabolites. Co-expression analysis by weighted
gene co-expression network analysis (WGCNA)26 supports the
notion that BR participates in electron transport and OXPHOS in
multiple human organs and species (Fig. 3a, Supplementary
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chain are dynamically regulated by energy status. In response to a
reduction of cellular ATP:ADP ratio, such as during nutrient
depletion or exercise, the energy-sensing AMP-activated protein
kinase (AMPK) pathway restores energetic balance by stimulating
ATP-producing catabolic pathways and inhibiting energy-
consuming anabolic processes27. As such, we hypothesized that
BR levels would be regulated by cellular energy status. Indeed,
activation of AMPK using 5-aminoimidizole-4-carboxamide-1-β-
D-riboside (AICAR)28 robustly increased protein levels of BR
(Fig. 3b). Likewise, BR increased in response to glucose, serum
and fatty acid starvation, in parallel with AMPK activation
marked by phosphorylation of Acetyl-CoA carboxylase (ACC), a
direct AMPK target29 (Fig. 3c). In mouse myotubes, enforced
expression of PGC-1α, the AMPK-activated regulator of mito-
chondrial biogenesis30, robustly induced Br expression along with
other OXPHOS components (Supplementary Fig. 3b). These data
together indicate that BR is under the regulatory control of the
AMPK- PGC-1α energy homeostasis axis, and predict that a loss
of BR would impair cellular bioenergetics and mitochondrial ATP
production. To investigate this, we silenced BR in U87MG
glioblastoma cells (a highly oxidative cell type) using both
transient siRNA and stable shRNA-mediated approaches. Indeed,
BR depletion significantly decreased basal, maximal respiration,
spare capacity, and reduced ATP production in both siBR and
shBR U87MG (Fig. 3d–f, Supplementary Fig. 3c). Likewise,
HEK293T grown in galactose displayed the same reduction in
basal respiration (Supplementary Fig. 3d), which sufficiently
perturbed cellular ATP:ADP ratio to activate AMPK (Supple-
mentary Fig. 3e). These data confirm that BR is essential for
cellular bioenergetics, potentially through regulation of the
electron transport chain.
Deletion of Br in zebrafish causes mitochondrial disease. BR is
highly conserved in vertebrates, suggesting that its role in bioe-
nergetics is fundamental and required throughout evolution. To
understand the in vivo requirement of BR in animal physiology,
we turned to the zebrafish where br is most highly expressed in
skeletal and cardiac muscle (Fig. 4a). Using Crispr/Cas9, we
generated protein null br knockout animals (KO) by removing
the entire protein-coding ORF contained in exons 2 and 3
(Supplementary Fig. 4a and Fig. 4b). br zygotic KO (zKO) larvae
were produced at Mendelian ratios (Fig. 4c) with no gross
development defects within the first 5 days besides a delay in
swim bladder inflation (Supplementary Fig. 4b, c). Muscle for-
mation was normal with no overt signs of myopathy or dystrophy
(Supplementary Fig. 4d). However, if left unsegregated, br zKOs
could not be recovered by 65 days post fertilization (dpf) (Fig. 4c).
We therefore segregated larvae from intercrosses at 3 dpf and
allowed them to grow at low density. Under this regime, zKO
juveniles survived into adulthood, but displayed growth retarda-
tion from 28 dpf (Fig. 4d) that resulted in large differences in
body size by 65 dpf (Fig. 4e). zKOs are sub-fertile, and can
generate maternal zygotic knockout embryos (mzKO) albeit at a
very low frequency (~1/20 mating pairs). Because Br is a mito-
chondrial peptide, it is maternally deposited in oocytes. mzKOs
therefore lack any residual Br protein that is available to zKOs
during the initial phases of larvagenesis. Consequently, mzKO
Fig. 1 Mito-SEP prediction pipeline identifies uncharacterized endogenous mitochondrial SEPs. a Size distribution of curated human proteins annotated
as mitochondria (1172 proteins), cytosolic (5806 proteins), or secretory (3351 proteins) on Uniprot. p-value by two-sided Mann–Whitney U-test. n.s.= not
significant. b Size distribution of Uniprot proteins (All) (20417 proteins) annotated to reside in mitochondria (1172 proteins) or inner mitochondrial
membrane (IMM) (292 proteins). p-value by two-sided Mann–Whitney U-test. c Percentage of proteins smaller than 100 a.a. in different cellular
localizations. d Human SEP selection and mitochondrial prediction workflow. Blue numbers indicate number of SEPs and green numbers indicate number of
genes encoding these SEPs. e HA immunofluorescence (green) of mito-SEP candidates showing colocalization with Mitotracker Red (red) in HeLa cells.
Uncharacterized SEPs are labeled as mitochondrial SEP with unknown function (MSUF). Scale= 20 μM. f Circular plot of expression correlation between
MSUF and MSigDB gene ontology (GO) gene sets that relate to oxidative phosphorylation. The width of each connector represents the normalized
enrichment score (NES) value of the gene set enrichment analysis (GSEA) analysis performed on a ranked list of MSUF-coexpressed genes determined by
weighted gene co-expression network analysis (WGCNA). The black bar indicates the score of the 90th percentile of the score of 1000 randomly selected
genes. CDC42SE2 depicts the position of a non-mitochondrial negative control with NES= 0.
Table 1 List of verified mito-SEPs.
Label Name Gene ID Locus Motif Length (a.a.)
BRAWNIN BRAWNIN ENSG00000204954 sORF SP 71
MSUF1 PIGBOS1 ENSG00000225973 sORF TMD 54
MSUF2 LINC01560 ENSG00000196741 lncrna Not detected 94
MSUF3 LINC00473 ENSG00000223414 lncrna TMD 90
MSUF4 SMIM12 ENSG00000163866 sORF TMD 92
MSUF5 SMIM26 ENSG00000232388 sORF TMD 95
MSUF6 C16ORF91 ENSG00000174109 sORF TMD 65
MSUF7 PRPF19 uORF ENSG00000110107 5UTR MTS 66
MSUF8 UBQLN1 uORF ENSG00000135018 5UTR MTS 53
MSUF9 RNASEH2C uORF ENSG00000172922 5UTR MTS 79
MSUF10 CENPW uORF ENSG00000203760 5UTR MTS 68
MSUF11 MRPL24 uORF ENSG00000143314 5UTR Not detected 77
MSUF12 TMEM222 uORF ENSG00000186501 5UTR TMD 90
MSUF13 EIF3K uORF ENSG00000178982 5UTR Not detected 59
MSUF14 KIAA0100 uORF ENSG00000007202 5UTR TMD 73
MSUF15 SLC35A4 uORF ENSG00000176087 5UTR TMD 96
MTLN LINC00116 ENSG00000175701 sORF TMD 56
MIEF1 uORF MIEF1 uORF ENSG00000285025 5UTR MTS 70
SP signal peptide, TMD transmembrane domain, MTS mitochondrial targeting sequence.
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Fig. 2 BRAWNIN (BR) is a conserved SEP at the inner mitochondrial membrane. a Ribosome protected fragment (RPF) reads from the BRAWNIN gene
(C12orf73) in human cell lines. P1 and P2 refer to the 2 potential ORF isoforms generated by alternative splicing. b BR (P1) peptide is conserved throughout
vertebrate evolution and possesses an N-terminal hydrophobic region that is predicted to be a transmembrane domain or signal peptide. Underlined regions are
peptides detected by mass spec. Regions used as immunogens for raising the polyclonal antibodies used in this study are indicated. c Endogenous BR is
detected in HeLa and HEK293T with an α-BR antibody. OE= overexpression. d Western blot of HEK293T lysates transfected with control or BR-targeting
siRNAs. e Immunofluorescence of endogenous BR detected by α-BR in HeLa transfected with control or BR-targeting siRNAs. Scale= 5 μM. f Western blot of
indicated proteins from subcellular fractions of HEK293T. W = whole cell, M = mitochondria enriched fraction, C = cytosol, P = nuclear fraction and debris,
including un-extracted mitochondria; BRΔN25= synthetic BR peptide lacking the N-terminal 25 a.a. g Endogenous BR detected by α-BR in HeLa costained with
mitotracker. Scale= 5 μM. h Endogenous BR detected by α-BR in HEK293T costained with mitotracker. Scale= 5 μM. i α-BR and α-citrate synthase (CS)
immunofluorescence in mouse skeletal muscle, longitudinal section. Scale= 20 μM. j α-BR immunofluorescence and GFP epifluorescence of Mito-Dendra2 in
mouse skeletal muscle, longitudinal section. Scale= 20 μM. k Extraction of endogenous BR from HEK293T mitochondria with buffer alone, Na2CO3 solution or
buffer containing 1% Triton X. S= supernatant; P = pellet. l Extraction of endogenous BR from HEK293T mitochondria using increasing concentrations of
digitonin. TOMM20, TOMM70, and VDAC1 are outer mitochondrial membrane (OMM) proteins, are MTCO1, ATP5A, and TIM23 are IMM associated.
m Proteinase K protection assay of HEK293T mitochondria. The α-BR epitope is C-terminal to the predicted transmembrane domain. TOMM20 and TOMM70
have cytosolic domains. TIM23 has IMS domains. Both CS and ATP5A are in the matrix.
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had a more severe phenotype compared to zKOs (Fig. 4d). By 6
dpf, mzKO larvae were visibly less active despite fully inflated
swim bladders (Supplementary Fig. 4e). By 7 dpf, at the onset of
feeding, their food intake was significantly less than WT larvae
(Supplementary Fig. 4f). By 11 dpf, they displayed a dramatic
reduction of directional swimming and distance swam compared
to WTs (Fig. 4f and Supplementary Fig. 4g). Consequentially,
mzKO larvae did not increase in body length even under low
density segregated growth conditions, and did not survive past 42
dpf under the conditions of our aquatics facility (Fig. 4d). In line
with our observations in human U87MG cells, basal, ADP sti-
mulated, maximal respiration, and ATP production in br KO
skeletal muscle mitochondria were reduced to half that of WT
(Fig. 4g). This in turn significantly reduced whole animal
respiration br mz KO compared to WT larvae even as early as 1
dpf (Fig. 4h), leading to a failure to thrive and early death
(Fig. 4d). These data provide evidence that BR is mito-SEP with
conserved and critical functions in mediating OXPHOS, and
in vivo deletion of br causes severe mitochondrial deficiency
leading to growth retardation.
BRAWNIN is required for respiratory chain complex III. To
understand the molecular basis of the mitochondrial defect in br
KO fish, we profiled the metabolomic perturbations in whole
mzKO larvae at 5 dpf. Targeted metabolomics analysis revealed a
2-fold increase in the levels of lactate in mzKO larvae (Fig. 5a)
and a 3-fold increase in the citric acid cycle intermediate succi-
nate as compared to WT larvae (Fig. 5b). Lactate accumulation is
caused by decreased pyruvate oxidation secondary to mitochon-
drial deficiency and is frequently used as a diagnostic symptom
for patients with mitochondrial diseases31. To understand what
molecular defects in the mitochondria could result in these per-
turbations, we turned to MitoCore, a metabolic flux model that
simulates over 300 mitochondrial reactions in a human cardio-
myocyte using flux balance analysis32. By blocking each reaction
in turn, and simulating 5000 feasible flux states for each possible
blockage, we found that inhibiting ETC Complex III (CIII, Fig. 5c
and Supplementary Fig. 5a) and Complex IV (CIV, Supplemen-
tary Fig. 5b) flux caused the largest, most biologically plausible
increase in succinate and lactate (as inferred from the export rate
of the two metabolites). Similarly, when we deleted each of the
371 genes in the MitoCore model, the deletion of genes encoding
CIII and CIV components caused the largest increase in succinate
and lactate (Supplementary Table 1). In contrast, inhibiting
Complex II was not sufficient to induce the observed elevations in
lactate (Supplementary Fig. 5c). These data suggest that the
underlying molecular defect in br KO mitochondria is related to
CIII and/or CIV dysfunction.
To investigate this possibility, we constructed the BR inter-
actome in HEK293T mitochondria by co-immunoprecipitating
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Fig. 3 BR is an AMPK target that potentiates OXPHOS in human U87MG cells. a Heatmap depicting GSEA NES scores of mitochondrial pathways
(Supplementary Data 2) in the ranked list of pairwise correlations between genes in the human liver, heart, or skeletal muscle (SKM) with either BR gene,
known electron transport gene ATP5H or CDC42SE2, a representative non-mitochondrial candidate SEP. b SDS-PAGE of HEK293T treated with AMPK
activator AICAR (500 µM) for the indicated time periods. c SDS-PAGE of HEK293T treated with indicated starvation regimes for the indicated time
periods. Etomoxir was used at 3 µM. d Mitostress test (Agilent Seahorse) analysis of control versus stable BR knockdown U87MG cells. Oxygen
consumption rate (OCR) reads were normalized with citric synthase (CS) activity. Data are mean and SEM of six technical replicates. Experiment is
representative of two biological replicates. Oligo = oligomycin, FCCP = carbonyl cyanide 4-(trifluoromethoxy)phenylhydrazone, Rot/AA = rotenone/
antimycin A. e Analogous to d. except using short-term (72 h) siRNA-mediated depletion of BR. The experiment is representative of three biological
replicates each with six technical replicates. Error bars represent SEM. f Spare respiratory capacity calculated from experiments in d and e. Data are mean
and SEM of six technical replicates which are representative of two and three biological replicates for shRNA and siRNA-mediated depletion, respectively.
p-values from two-sided unpaired t-test.
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either endogenous or overexpressed BR followed by mass
spectrometry (IP/MS). At the intersection of 4 independent IP/
MS experiments were three proteins: BR, GHITM, and UQCRC1
(Fig. 5d, Supplementary Data 3). UQCRC1 is a core component
of CIII33 while GHITM has been proposed to regulate
cytochrome c release during apoptosis34. The interaction with
GHITM could not be validated with several commercially
available antibodies. In contrast, the interaction between BR
and UQCRC1 detected in human cells was validated by co-
immunoprecipitation(co-IP)/western blot in digitonin-solubilized
mouse heart mitochondria expressing a Br-FLAG construct
(Fig. 5e). Likewise, BR was co-immunoprecipitated by CIII
subunit UQCRQ using a surface exposed C-terminal FLAG tag in
HEK293T (Fig. 5f). These data suggest that BR, an IMM peptide,
directly interacts with the respiratory chain at CIII.
Among all genes encoding RC proteins, BR transcript
expression correlates most strongly with those encoding CIII
assembly factors (Supplementary Data 4). On this basis, we
hypothesized that the observed respiratory defects in si/shBR
U87MG and br KO fish are caused by CIII deficiency. To address
this possibility, we performed quantitative proteomics on isolated
skeletal muscle mitochondria from br WT and KO animals
(Fig. 6a). Strikingly, we found that 5 subunits of CIII were
significantly downregulated, while subunits of CI, II and IV were
not significantly affected (Fig. 6b, c, Supplementary Data 5),
suggesting that CIII stability or assembly is specifically impaired
in the absence of br. Indeed, SDS-PAGE analysis of br KO
mitochondria confirmed that total Uqcrc1 and Uqcrc2 levels were
reduced by >80% (Fig. 6d, e) resulting in a >90 % reduction of
mature CIII dimers (CIII2) as measured by Uqcrc1, Uqcrc2,
Uqcrh and Uqcrb densitometry in blue-native (BN)-PAGE
(Fig. 6f). The specific reduction in CIII2 was also seen in shBR
U87MG cells both at steady state (Supplementary Fig. 6a–c) and
during active assembly of respiratory chain complexes released
from doxycycline-mediated inhibition of mitochondrial transla-
tion (Supplementary Fig. 6d). Furthermore, deletion of murine Br
in mouse embryonic fibroblasts (MEF) (Supplementary Fig. 6e, f)
likewise resulted in reduction of CIII subunit proteins levels and
assembled CIII2 (Supplementary Fig. 6g, h), demonstrating that






















































































































































Fig. 4 Knockout of Br in zebrafish causes lethal mitochondrial deficiency. a In-situ hybridization (ISH) of brawnin (br) in zebrafish larvae. dpf= days post
fertilization. Left panel: scale= 100 µm, right panel: scale 200 µm. b Western blot analysis of purified mitochondria from adult WT and KO (homozygous
brΔ/brΔ) skeletal muscle using zebrafish-specific α-Br. c Mendelian percentages of offspring from heterozygous (Het) intercrosses genotyped at the
indicated dpf. Data represent the mean of at least 2 clutches per time point (except 28 and 124 dpf) with at least 15 animals per clutch. Error bars indicate
SEM. d Standard length (mm) measurements of WT, Het, and zygotic KO (zKO) larvae generated from an F2 intercross genotyped and segregated at 3 dpf.
Maternal zygotic KOs (mzKOs) were generated from a homozygous incross and measured until 42 dpf when all animals succumbed to disease. Data are
representative of four independent experiments from two independent Cas9/gRNA injected brΔ KO allele founders. Number of animals at the beginning of
the experiment: WT= 14; HET= 37; zKO= 8; mzKO= 22. Error bars indicate SEM. e Representative images of WT, Het, and zKO clutch-mates at 65 dpf.
Scale= 5mM. f Basal motility monitoring continuous swim tracking of WT and mzKO larvae at 11 dpf. 23 animals per genotype monitored. Error bars
indicate SEM. g Coupled respiratory analysis of isolated SKM mitochondria measured on Agilent Seahorse in the presence of succinate+ rotenone, read
out as CS-normalized OCR. Basal, ADP stimulated, maximal respiration and ATP production were plotted. Data represent mean and SEM of four biological
replicates. p-values from two-sided paired t-test. h Basal respiratory rate of free moving 1 dpf WT and mzKO larvae measured on Agilent Seahorse
platform. Number of animals: WT1= 30; WT2= 15; KO1= 21; KO2= 23. Data represent mean and SEM, p-values from two-sided unpaired t-test.
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higher vertebrates. Furthermore, Br KO MEFs activated the
AMPK pathway due to the energetic perturbation caused by CIII
deficiency (Supplementary Fig. 6i). Finally, the observed reduc-
tions in CIII protein levels led to significant reduction of all CIII
activity as measured by spectrophotometric measurement of RC
enzymatic activities35 (Fig. 6g), while CI, CII, and CIV activities
were not significantly affected. Altogether, our data demonstrate
that the loss of Br in zebrafish causes overt and lethal
mitochondrial deficiency due to the specific loss of CIII in the
respiratory chain.
Discussion
Our findings in this report demonstrate that SEPs are pre-
ferentially enriched in the mitochondria and play programmatic
functions in oxidative respiration. We speculate that this size bias
might simply reflect the endosymbiotic origins of the mito-
chondrion. However, since the mito-SEPs including BR found in
this study are not conserved in prokaryotes, an alternative
explanation lies in the energetic barrier imposed by the double
membranes of the mitochondrion against protein import. Simply
put, it is energetically less costly to import small proteins than
large proteins. For an organelle that is primarily responsible for
maintaining energy balance, such a strategy would allow the
mitochondrion to lower the cost of its own biogenesis during a
time of increased ATP demand, allowing homeostasis to be
reached in a shorter time frame.
The mechanism with which BR promotes CIII assembly and/or
stability also calls for greater in-depth investigation. The assembly of
complex III in mammals is poorly understood and largely inferred
from studies performed in yeast36. In zebrafish, loss of Br caused
complete attenuation of the fully assembled 500-kDa CIII2, with no
evidence of immature pre-CIII2 assemblies seen in mutants of late
assembly factors37–39, arguing that Br acts early in the biogenesis
and known sequence of CIII assembly before dimerization of
assembly intermediates37. Consistent with a possible direct role of
Br as a CIII assembly factor in vivo, BN- and SDS-PAGE
demonstrated partial co-migration of endogenous Br with CIII2
in zebrafish mitochondria (Supplementary Fig. 6j, k). However, our
data currently cannot exclude the possibility that BR mediates CIII
biogenesis by facilitating the import of its constituent subunits or
their stability following translation/import, which will require fur-
ther investigation. BR is highly responsive to energy status. Elec-
trons transferred from the oxidation of divergent fuel types
converge at CIII. Because CIII is the center of the respiratory chain,
we speculate that BR, acting as an early CIII assembly factor,
coordinates the bioenergetic output of the respiratory chain with
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Fig. 5 Br functionally and physically interacts with electron transport chain complex III. a Lactate concentrations in 5 dpf WT and mzKO larvae. Data
represent mean and SEM of four independent clutches each with 50 larvae per genotype. p-values from two-sided paired t-test. b Citric acid cycle organic
acid concentrations in 5 dpf WT and mzKO larvae. Data represent mean and SEM of four independent clutches each with 50 larvae per genotype. p-values
from two-sided paired t-test with Bonferroni correction. *α-KG concentrations are a 10-fold multiple to enable visualization on the same scale.
c Distributions of the export rate of lactate and succinate (5000 flux samples) comparing the unconstrained MitoCore model versus the CIII-blocked
model derived by MitoCore flux balance analysis (FBA). d Venn diagram depicting intersections of proteins identified in 4 co-IP/mass spec experiments of
BR in HEK293T mitochondria. Endogenous BR and overexpressed untagged BR were immunoprecipitated with α-BR, overexpressed BR-FLAG with α-FLAG.
e Immunoprecipitation of BR-FLAG followed by immunoblotting for indicated ETC proteins from mouse mitochondria with AAV9-mediated expression of
BR-FLAG. MTCYB, UQCRFS1, UQCRC1, and UQCRH are components of CIII. NDUFA9 and COX4 are components of CI and CIV, respectively. f. Reciprocal
IP of BR with CIII components. UQCRQ-FLAG and BR-HA were co-transfected into HEK293T. UQCRQ-FLAG immunoprecipitation was followed by
immunoblotting for BR-HA and indicated proteins. CS is an unrelated matrix protein.
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Fig. 6 Br is required for complex III assembly and activity. a Quantitative proteomic analysis of WT and br zKO isolated adult skeletal muscle (SKM)
mitochondria. Mean values of log2 fold change (zKO/WT) for each detected protein from three biological replicates are plotted in a volcano plot. Subunits
of each of the ETC complexes are labeled in the indicated colors. CI–CV= Complex I–Complex IV. p-values from two-sided unpaired t-test. b The median
log2 fold change (zKO/WT) of all detected ETC proteins are further depicted in a dendrogram heatmap and separated by complex membership. AF =
assembly factors. c The median log2 fold change (zKO/WT) of CI–CIV proteins were superimposed onto the structures of human CI–CIV to visually depict
the observed changes. The same scalebar from panel 6b applies. Undetected proteins are shown in gray. d SDS-PAGE of purified WT and zKO SKM
mitochondria followed by immunoblotting for the indicated ETC proteins. Image is representative of two experiments. e Quantitation of SDS-PAGE in 6d.
Data represent mean and SEM. n= 5, except for Uqcrc2 where n= 3. p-values from two-sided unpaired t-test. f BN-PAGE and western blot analysis of WT
and zKO SKM mitochondria. Position of free III2 (red) and III2+ IVn (black) supercomplexes are indicated by arrowheads. g Spectrophotometric respiratory
chain activity assay (RCA) of WT and zKO SKM mitochondria. Data represent mean and SEM. Each dot represents one animal, n= 12 for WT and zKO
animals. p-values from two-sided unpaired t-test.
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BR levels affect cellular AMPK status. This raises the possibility that
BR, through regulation of AMPK activation, might also be involved
in regulating intra-hepatic lipid accumulation40, a hypothesis that
remains to be investigated. Recently, CIII integrity has been
implicated in regulatory T cell function and the prevention of
autoimmunity41, raising the intriguing possibility that BR can also
coordinate nutrient availability with immune function. Lastly,
congenital CIII defects resulting from mutations in CIII subunits or
assembly factors cause very rare but severe mitochondrial disease
characterized by growth retardation, lactic acidosis, aminoaciduria
and early death42,43. The phenotypic similarities of the br KO
zebrafish sets the basis to screen unsolved cases of mitochondrial
disease for pathogenic variants in the BR (C12orf73) gene and
potentially the genes encoding the other mito-SEPs described here.
In conclusion, by performing a screen of the SEP peptidome,
we report the discovery of BRAWNIN, a mitochondrial peptide
that is central to vertebrate oxidative phosphorylation. This
emerging theme of the preponderance of SEPs in the mito-
chondria is seen also in the human heart8, pointing to the in vivo
significance of mito-SEPs in human physiology. When this
manuscript was in revision, Saghatelian and colleagues reported
the independent discovery of PIGBOS (MSUF1 in this study) as a
mitochondrial peptide that mediates the unfolded protein
response in the endoplasmic reticulum44, underscoring the bio-
logical diversity of mito-SEPs. Of high priority is deducing the
contribution of the other 14 mito-SEPs to oxidative metabolism.
Our work demonstrates the promise and value of mining and
characterizing the sORF-encoded peptidome, which should
motivate similar efforts to functionally characterize remaining
uncharacterized SEPs, also known as Small GEms hidden in
Plain view.
Methods
sORF selection criteria. sORF-encoded peptides (SEPs) were filtered using ribo-
some profiling-based metrics derived from sORFs.org, adapting the guidelines from
Olexiouk et al.45. In all, 2343 human SEPs encoded by annotated short CDS genes,
lincRNAs, upstream ORFs (uORFs), and intergenic ORFs that passed ribosome
sequencing quality thresholds were selected for mitochondrial prediction (Ensembl
annotation bundle v92 is applied). From the pool of 115,223 predicted sORFs, a
minimum ORF-score of 646 was imposed on nucleus encoded sORFs. Extra fil-
tering criteria are set separately dependent on the sORF annotation. For the sORFs
annotated in CDS genes, a minimum threshold of 50% in-frame coverage and a
coverage uniformity between +1 and −1 was imposed, whereas for sORFs located
on lincRNA, an in-frame coverage of 50% and a coverage uniformity between −0.5
and 0.5 was imposed. For sORFs located in the 5′-UTR region of protein coding
genes, a minimum in-frame coverage of 0.7, a coverage uniformity between −0.3
and 0.3, a minimum length of 20 a.a. and a good FLOSS categorization was
imposed2. Also, these sORFs should be identified/predicted in at least 10 different
RIBO-seq datasets. For intergenic sORFs (i.e. in between genes), a minimal up- and
down-stream gene distance of 1000 nucleotides (>1 kb_nn), a minimal in-frame
coverage of 0.9, a coverage uniformity between −0.3 and 0.3, a minimum length of
20 a.a., a good FLOSS categorization, and a minimum number of identifications in
at least 1 RIBOseq dataset was imposed. This resulted in a pool of 2343 sORFs
encoded from 1027 different genes (Fig. 1C). See Supplemetary text for more
explanation of selection parameters.
Mitochondrial prediction by WGCNA and GSEA. RNA-seq datasets from three
human tissues known to be enriched in mitochondrial activity were selected to enable
mitochondrial functional prediction: non-neoplastic liver (21 samples from GSE94660
– RPKM normalized), normal heart left ventricular tissue (92 samples - VST counts)47
and normal skeletal muscle (84 samples from GSE120862 – DESeq normalized
counts). To compare those mitochondria-enriched tissues with a non-enriched one, a
sun-protected skin dataset (91 samples from GSE85861 – Normalized counts) was
selected. To clean the datasets, genes with at least one read in more than half of the
samples were kept except for the heart dataset. The healthy heart dataset is coupled to
a dilated cardiomyopathy (DCM) dataset and genes with at least one read in more
than 5% of the samples were kept. To distinguish between a mitochondrial and a non-
mitochondrial gene, we selected 1158 bona fide mitochondrial genes (“mito”) (from
Human MitoCarta2.0) for comparison against 957 nuclear transcription factors (TF)
randomly selected from www.tfcheckpoint.org (“non-mito”)16,48. These form the
“classifier genes”. We further selected 56 known MitoCarta genes that encoded
proteins <100 a.a. (i.e. mito-SEPs) and 83 annotated nuclear and secreted proteins
<100 a.a. (i.e. non-mito SEPs) which formed the mito vs non-mito SEP. These form
the “training genes”. We performed WCGNA with the WGCNA package in R26,49 for
all classifier and training set genes in all three datasets. i.e. we ranked all genes in a
dataset according to their Spearman’s correlation with each test gene. Next, we per-
formed GSEA50 using 7 gene set collections from MSig DB (Broad Institute)51,52:
c2.cp.reactome, c2.cgp, c2.cp.kegg, c5.cc, c5.bp, c5.mf, and h.all, which gather 10,260
gene sets. Using fgsea package in R53, the NES score of each gene set was calculated for
each ranked list. NES was set to 0 if the GSEA output p-value (using an empirical
phenotype-based permutation test procedure50) was not significant (p > 0.05). To
decrease noise and increase specificity to mitochondrial activity, only gene sets with at
least 100 mito genes with an absolute NES above three were kept and gene sets
containing more than 500 genes were removed. On average, each gene had 63, 85, and
118 NES values in the heart, liver and SKM dataset respectively. These scores were
used as variables for principal component analysis (PCA) using stats package. Alto-
gether, each PCA analysis contained 3090 observations (1956 classifier+139 training
+995 SEP candidate genes). Only 995 of the 1027 genes encoding 2343 SEP candi-
dates were expressed in any one of the three datasets and could be tested by this
method. Next, K-means clustering was applied to the PCA for a cluster number
varying from 2 to 15. For each iteration, clusters were ranked from the highest
percentage of mito genes to the lowest. To know if a cluster should be considered as
positive or negative for mitochondrial identity, each cluster’s mito percentage was
tested as a potential threshold. The threshold which led to the highest number of
correct prediction of the training set was kept. Clusters with a mitochondrial per-
centage below the threshold were considered negative, otherwise positive. Candidates
were given a binary score of 0 or 1 depending on whether they belonged to a negative
or positive cluster respectively. This process of binary scoring was made for every
cluster number, and each SEP candidate was given an average k-means score. K-mean
score was set to −1 if the gene was not expressed in the dataset. Based on the k-means
scores of the training set, it appeared that 75% was the minimum average k-means
score needed for a peptide to be predicted as mitochondrial. To be more stringent on
the selection we added the criteria of confidence level. “High confidence” meant that a
SEP candidate required an average k-means score above 75% in all RNAseq where it is
expressed. Refer to Supplemental Text for more information.
Mitochondrial prediction by targeting motif prediction. Mitochondrial targeting
motifs were predicted in peptides that were not selected by WGCNA/GSEA. Dif-
ferent types of mitochondrial targeting motifs were predicted using separate
algorithms. Classical mitochondrial targeting sequences (MTSs) were captured by
the consensus prediction of TargetP (mitochondria, Reliability class 1 & 2) and
Mitofate (score > 0.8) or Mitoprot (score > 0.8)54–56. Transmembrane domains
(TMDs) with modest hydrophobicity also serve as mitochondrial targeting signal,
but they are poorly predicted by algorithms used above because these sequences are
not cleavable. These hydrophobic α-helices were predicted by TMHMM or SignalP
(4.1 and 5)54,57. To eliminate secretory proteins, the maximum TMD hydro-
phobicity was set at 358, as we noticed that mitochondrial TMDs were on average
less hydrophobic compared to non-mitochondrial TMDs59. In addition, mito-
chondria intermembrane proteins often contain twin cysteine pairs (two C9XC,
two C3XC, or one C9XC and one C10XC, where X refers to any residues in
between two cysteine residues)60, and these internal signals are generally missed by
prediction algorithms. We thus included peptides with these characteristic cysteine
pairs in the screen.
Mitochondrial prediction by mitochondrial peptide RESPIN. Quantitative mass
spectrometry data on isolated mitochondria are available at the PRIDE public
proteomics data repository (accession number PXD004666)61 and downloaded
using the PRIDE API62,63. Subsequently, the raw data files were converted and
filtered using MSconvert64. Next, the SearchGui tool65 was used to perform the
peptide to spectrum matching, based on a combination of two database search
algorithms X!tandem66 and MSGF+67 against a custom sequence database. This
database consists of (i) the UniProt human functional proteome including all
isoforms68, (ii) the human sORFs from the sORFs.org database69, and (iii) the
cRAP database (https://www.thegpm.org/crap/). Search engine parameters were
adapted from the original study61. Matched PSMs were validated using Peptide-
Shaker70, only PSM solely mapping to sORF peptide sequences with a spectrum
coverage of at least 30% and FDR<0.01 were retained. After selecting peptides by
the three strategies, redundant isoforms were manually removed if they share
identical sequences with the longest isoform encoded by the same gene, with
ribosomal periodicity information been considered.
SEP transient over-expression. The open reading frames (ORFs) of selected can-
didates were synthesized and inserted into the NheI-XhoI site of a pcDNA3.1 (+)
vector, under the control of the CMV promoter. Peptides were tagged with a single
HA tag distal to their predicted targeting motifs or c-terminus if no motif was
predicted. ORFs with non-AUG start codons were replaced with a AUG start codon
to avoid the need for including cognate 3′UTRs required for recognizing near-cognate
start sites71. HeLa cells were seeded in 24-well plates and transfected with FuGENE
(Promega) and stained as described in the immunofluorescence section.
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Primer sequences. List of primers used in this study:
















Zebrafish Br knockout generation. zfBrawnin is encoded by the si:ch211-68a17
gene which contains 3 exons with the ORF in exons 2 and 3. EST mining on NCBI
and ENSEMBL mapping to this region in the zebrafish genome did not reveal the
presence of a duplicated allele or paralogue. To completely excise the ORF, we used
ZiFiT72 to design two gRNAs 5′ and 3′ to the ORF with recognition sites under-









gRNAs were generated from gBLOCKS with MEGAshortscriptTM T7 Kit
(Invitrogen, AM1354). Following DNaseI treatment and precipitation with NH4Ac
and ethanol, gRNAs were resuspended in 40 μl pure water. In all, 200 pg of each
gRNA was injected along with 300 pg of purified recombinant Cas9 protein (a kind
gift of Harwin Sidik) into 1 cell stage AB larvae. F0 founders were detected by
genotyping with the primers LHW4_zfBr_5′_F and LHW7_zfBr_3′_R.
WT undeleted band yields a 624-bp band while the deleted allele (brΔ) yields a
220-bp with HotStart Taq Polymerase (Qiagen). In all, 2 brΔ founders (ΔBig and
ΔSmall) with complete deletions were brought forward for characterization. Both
were backcrossed to AB until F2 before phenotypic investigations began. All data
showed in the paper are generated from F2 and F5 incrosses. Growth retardation
phenotype is stable throughout generations and reproducible to F6 when this
manuscript was prepared. Both founders showed similar growth defects. All data
presented are derived from ΔBig but are representative of ΔSmall, which had a
more severe phenotype.
Zebrafish husbandry and growth tracking. Zebrafishes were reared under
standard conditions, 28 °C with approved protocols following regulations stipu-
lated by the IACUC committee of A*STAR Singapore. Heterozygous crosses were
performed starting at the F2 generation to produce WT, Hets, and zygotic KO
larvae. These were housed at a density of 50 per tank. In all, 15–20 animals were
randomly selected and genotyped every week by scaling to track Mendelian
representation over time under conditions of unsegregated growth. Briefly, scales
were lysed in 50 mM NaOH at 95 °C for 15 min followed by neutralization with 1/
10th volume Tris-HCl pH 8.0 and debris pelleted by centrifugation at 3000 × g for
5 min before PCR with LHW4_zfBr_5′_F and LHW7_zfBr_3′_R primers listed
above. To enable segregated growth, larvae were genotyped at 3dpf by clipping the
tip of the tail fin73 and housed at a lower density of 20/tank. KO fish were given one
extra feed per day to boost their growth. The standard length of these larvae were
measured once every week under a stereoscope (up to day 28) or with a ruler after
minimal tricaine anesthetization. Br KO fish that survive past 4 months have a
short mating span of about 2 months to generate maternal zygotic (mz KO) larvae.
Beyond that point, we notice that the Br KO males fail to display effective mating
behavior due to their low body weight and lethargic phenotype. Female Br KO
females are however, still able to mate with WT or Het fish, demonstrating pre-
servation of their fertility.
Birefringence analysis. In all, 4–6 dpf larvae were anaesthetized briefly with tri-
caine before embedding in 30% methylcellulose in the egg water. Imaging was
performed by placing the dish containing the larvae in between a pair of polarized
filters (50 mm Diameter Unmounted, Linear Glass Polarizing Filter, Stock No. #43-
787 from Edmund Opticals) aligned at 90° to each other. Images were collected
under brightfield with a Nikon SMZ800 stereoscope connected to a CCD camera.
Zebrafish motility monitoring. In all, 5 dpf mz KO and WT larvae were gently
pipetted into a 48-well plate, each fish per well for monitoring locomotor activity.
The 48-well plate was placed in a sound-attenuated incubator to isolate it from
extraneous noise and light. Inside the incubator, a while-light LED box was
positioned below the plate and videos were recorded from the top at a speed of 5.3
frames per second (5.3 fps) by a Basler USB3 camera in a resolution of 2048 × 1024
pixels. The position (x-y coordinates) of the fish was determined in real-time based
on background subtraction algorithms written in Python utilizing OpenCV library.
This data was then exported into Microsoft Excel files and analyzed offline for
speed and distance measures.
Zebrafish respiratory analysis. Manually dechorionated 24 hpf (1 dpf) mz KO
larvae were placed into each well (1 per well) of an Agilent XF96e Spheroid
microplate containing 180 ul of sea salt water and allowed to adapt for 1 h. Basal
respiration was recorded on the Seahorse XF96e at 28 °C. This was achieved by
placing the XF96e in a refrigerated chamber held at 16 °C. We were unfortunately
unable to perform a Mito Stress test on live larvae because the repeated mixing
steps following injection of Oligomycin and FCCP caused significant lethality to
the larvae due to the low height clearance of the XF96e oxygen probe.
Zebrafish metabolomic analysis. At 5 dpf, 50 WT or mz KO larvae were col-
lected into a tube under normal conditions, placed on ice for 5 min to immo-
bilize larvae, followed by gentle sedimentation. All egg water was removed and
larvae were rinsed washed twice with ice cold water. The dried pellet was
weighed to 2 decimal points in mg and snap frozen, thawed on ice and homo-
genized in 50% H2O/50% Acetonitrile using zirconia beads in a liquid nitrogen
cooled rotor (2 cycles of 5000 × g for 20 s). For organic acid extraction, 300 µL of
tissue homogenate was extracted with ethylacetate, dried and derivatized with N,
O-Bis(trimethylsilyl)trifluoroacetamide, with protection of the alpha keto groups
using ethoxyamine (Sigma Aldrich, USA). The mixture was allowed to equili-
brate for 30 s and 1.2 mL of HPLC grade methanol was added to the mixture.
After vortexing, the mixture was incubated in 50 °C for 10 min and centrifuged
to pellet the precipitated protein. The supernatant was removed and dried under
nitrogen gas in a clean microcentrifuge tube. The dried extract was reconstituted
in 100 µl of methanol before analyzing using a liquid chromatography–mass
spectrometer. Trimethylsilyl derivatives of organic acids were separated by gas
chromatography on an Agilent Technologies HP 7890A and quantified by
selected ion monitoring on a 5975C mass spectrometer using stable isotope
dilution. The initial GC oven temperature was set at 70 °C, and ramped to 300 °C
at a rate of 40 °C/min, and held for 2 min.
MitoCore modeling. The Mitocore model was downloaded in SBML format from
Zieliński et al.32. Each of the 485 reactions in the model was blocked (setting upper
and lower bounds of permissible flux to zero), one reaction at a time, and the ATP
production (Reaction ID: “OF_ATP_MitoCore”) was constrained to have a flux
>90% of the theoretical capacity of the blocked model. Uniform sampling was
performed for each blocked model using the CHRR algorithm of Cobra toolbox 3.0
to obtain 5000 flux vectors that represent the solution space. As baseline com-
parison, the unchanged MitoCore model (unconstrained model) was also sampled
to obtain 5000 flux vectors. The flux distributions for the export reactions of
Lactate (Reaction ID: ‘L_LACt2r’) and Succinate (Reaction ID: ‘SUMt_MitoCore’)
were compared between the unconstrained model and each of the 485 constrained
models using the Wilcoxon ranksum test, and the effect sizes were computed using
Cohen’s d. Reaction blockages that produced a negative effect size for either lactate
or succinate export were discarded, and the remaining blocked models were ranked
by the sum of effect sizes (for Lactate and Succinate). A similar workflow was
repeated to identify which of the 371 genes in the MitoCore model had largest
effect size to increase succinate and lactate export when knocked out (Single Gene
Deletion studies using Cobra Toolbox 3.0)74.
Mitochondria flux assays. Respirometric analysis of purified mitochondria from
zebrafish skeletal muscle was performed using Agilent’s Seahorse platform as
described by Boutagy et al.75. Briefly, 1.0–1.4 µg of purified mitochondria were
plated in each well of a XF96e cell culture plate. To measure uncoupled electron
flow, assay buffer contained 5 mM pyruvate, 4 µM carbonyl cyanide 4-(tri-
fluoromethoxy) phenylhydrazone (FCCP), 1 mM malate. Rotenone (2 µM, final),
succinate (5 mM, final), antimycin A (4 µM, final), TMPD/ascorbic acid (100 µM/
10 mM) were injected sequentially during the assay. In coupling assay with pyr-
uvate and malate, assay buffer contained 10 mM pyruvate and 5 mM malate. In
coupling assay with Complex I inhibited, assay buffer contained 10 mM succinate
and 2 µM rotenone. In coupling assay, ADP, oligomycin A, FCCP and antimycin A
were injected into assay plate sequentially to 3.2 mM, 3 µM, 4 µM and 4 µM,
respectively. Citrate synthase activity (described below) was used for post-
normalization of OCR rates.
Mitochondria purification from cultured cells and tissues. Mitochondria were
isolated from cultured cells using mitochondria isolation kit (Abcam, ab110168).
Cells were harvested and ruptured with a Dounce homogenizer in the buffer A
containing cOmplete protein inhibitor cocktail (Roche) and 1 mM phe-
nylmethylsulfonyl fluoride (PMSF). 15 stokes were performed with a motorized
pestle operated at 300 rpm. Nuclei and unbroken cells were removed by cen-
trifugation at 600 × g. Homogenates were spun at 7000 × g for 15 min to pre-
cipitate mitochondria. Mitochondria pellets were collected for downstream uses.
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To isolate mitochondria from zebrafish, skeletal muscles of fish were dissected
and minced. Tissue was disrupted in muscle mitochondria isolation buffer
(67 mM sucrose, 50 mM KCl, 1mM EDTA, 0.2% fatty acid free BSA, 50 mM Tri-
HCl, pH7.4) with a Dounce homogenizer tight pestle operated at 1300 rpm. The
extract was centrifuged at 600 × g for 5 min to clear intact myofibrils and heavy
cell debris and then spun at 7000 × g for 15 min to isolate the desired mito-
chondrial fraction.
Antibody generation. Custom polyclonal antibodies were generated against
human BR (hBR) and zebrafish BR (zBr) using the following peptide antigens.
For SDS-PAGE, BN-PAGE, IF and IHC of human/mouse BR: 5′-
EVVHRYYRPDLTIPEIPPKRGELKTELLGLKERKHKPQVSQQEELKC-3′
For SDS-PAGE of zBr: 5′-RPDLSIPEIPPKPGELRTELLGLKERQMDSQKQ-3′
For BN-PAGE of zfBr: 5′-RPDLSIPEIPPKPGELRTEC-3′
Peptides were conjugated to KLH and used for rabbit immunization according
to standard procedures.
Immunofluorescence and immunohistochemistry. Cells were fixed by 4% PFA at
37 °C for 20 min and washed with PBS twice. Where appropriate, cells were stained
with 25 nM of Mitotracker Red at 37 °C for 30 min before the fixation. Samples
were solubilized with 0.3% Triton X at room temperature for 10 min and washed
twice with PBS. Cells were blocked with blocking buffer (3% BSA, 10% FBS in PBS)
at room temperature for 1 h. Primary antibodies were diluted to desired con-
centrations in the blocking buffer and incubated with cells for over-night, rocking
at 4 °C. Proteins of interest were probed with the following antibodies: anti-BR,
1:200 (Novus, NBP1-90536); anti-HA, 1:500 (BioLegend, 901502); anti-CYTC,
1:500 (Santa Cruz, sc-13561); anti-CS, 1:500 (Santa Cruz, SC-390693); anti-
TOMM20, 1:500 (Proteintech, 11802-1-AP). Cells were washed with three changes
of PBS-Tween 20 0.1% (v/v) before incubating with 4 μg/mL of secondary anti-
bodies for 1 h at room temperature (Alexa fluro 488, 594, 647, Invitrogen). In
mouse skeletal muscle staining, cryosections were air dried and fixed with 4%
formaldehyde in PBS at 4 °C for 10 min Samples were solubilized and blocked in
PBS containing 0.3% TX-100 and 5% normal goat serum at 4 °C for 1h. Primary
antibodies were prepared in PBS containing 1% normal goat serum and 0.1% TX-
100 and incubated for over-night at 4 °C. anti-BR, 1:200; anti-CS, 1:500 (Santa
Cruz, SC-390693) were used for muscle staining. Slides were washed times with
PBS containing 0.1% TX-100 and incubated with 4 μg/mL of secondary antibodies
for 1 h at room temperature (Alexa fluro 488, 594, 647, Invitrogen). Samples were
imaged on an Olympus FV3000 confocal laser scanning microscope. FFPE sections
of deidentified human cardiac and muscle tissues were purchased from US Biomax,
dewaxed and stained according to standard procedures with anti-BR 1:200 followed
by anti-rabbit HRP.
Immunoblotting. Whole cell or mitochondrial samples were lysed in RIPA buffer
supplemented with cOmplete protein inhibitor cocktail (Roche) and 1 mM phe-
nylmethylsulfonyl fluorid (PMSF). When appropriate, protein concentration was
measured by bicinchoninic acid (BCA) assay (Thermo Fisher). Lysates were boiled
in 1X laemmli sample buffer (50 mM Tris-HCl pH6.8, 2% SDS, 10% glycerol,
12.5 mM EDTA, 0.02% bromophenol blue, 50 mM DTT). After resolving by SDS-
PAGE in NuPAGE MES SDS running buffer (Thermo Fisher), proteins were
transferred to a 0.2-μM PVDF membrane (Thermo Fisher) and incubated in
blocking buffer (3–5% non-fat milk TBS-Tween 20 0.1% (v/v)) for 1 h at room
temperature. Membranes were probed with appropriate antibodies in TBST milk
for overnight, rolling at 4 °C. Following antibodies were used: anti-BR, 1:3000
(Novus, NBP1-90536); custom anti-human BR (1 µg/mL); custom anti-zebrafish
BR (1 µg/mL); anti-ACTIN, 1:5000 (Sigma, A2228); anti-TOMM20, 1:5000 (Pro-
teintech, 11802-1-AP); anti-CS, 1:2000 (Santa Cruz, SC-390693); anti-ATP5A,
1:5000 (Santa Cruz, SC-136178); anti-TOMM70, 1:5000 (AbClonal, A4349); anti-
VDAC1, 1:2000 (AbClonal, A0810); anti-MTCOI, 1:3000 (Abcam, ab14705); anti-
TIM23, 1:5000 (Proteintech, 11123-1-AP); anti-OXPHOS cocktail, 1:5000 (Invi-
trogen, 45-7999); anti-UQCRC1, 1:5000 (AbClonal, A3339); anti-NDUFA9, 1:3000
(AbClonal, A3196); anti-SDHA, 1:5000 (AbClonal, A2594); anti-TUBULIN, 1:5000
(Sigma, T9822); anti-ACC, 1:2000 (CST, 3662S); anti-pACC, 1:2000 (CST, 3661S);
anti-GAPDH, 1:5000 (CST, 2118S); anti-FLAG, 1:2000 (BioLegend, 637302); anti-
C4ORF48 (Abcam, ab185315); anti-COX4, 1:3000 (AbClonal, A10098); anti-
UQCRC2, 1:5000 (Abclonal, A4181); anti-UQCRFS1, 1:2500 (Abcam, Ab14746);
anti-UQCRH, 1:2500 (Abcam, ab134949); anti-UQCRB, 1:2000 (Sigma,
HPA043060); Anti-MTCYB, 1:2000 (Proteintech, 55090-1-AP); Anti-AMPK,
1:3000 (Bio-Rad, VMA00246); and Anti-pAMPK, 1:3000 (CST, 2535). Membranes
were extensively washed with four exchanges of fresh TBST and probed with HRP
conjugated secondary antibodies against mouse, rabbit or rat IgG at 1:5000
(Jackson ImmunoResearch) and washed again. Chemiluminescence was captured
by X-ray films (Santa-Cruz) or a Chemidoc imaging system (Bio-Rad). For
fluorescence blots, similar procedures were followed except that primary antibodies
and secondary antibodies was prepared in 3% BSA. IRDye 800CW goat anti-rabbit
and IRDye 680RD goat anti-mouse (Licor) were used at 1:10,000. Fluorescence
blots were scanned using Licor Image Studio.
Blue-native PAGE analysis. BN-PAGE analysis was performed as described by
Jha et al.76 and 2nd dimension BN-SDS PAGE as described by Fiala et al.77 with
minimal modifications. Isolated mitochondria were solubilized in BN-PAGE
sample buffer (Thermo fisher) with 8 g/g of digitonin on ice for 20 min. Every 50 μg
of mitochondrial proteins were solubilized in 20 μl of buffer. The insoluble fraction
was removed by centrifugation at 20,000 × g for 20 min 20 μl of solubilized protein
lysate was stained with 2.5 μl of 5% G-250 sample additive (Thermo fisher). Wash
wells of Native-PAGE 3–12% Bis-Tris protein gels with the dark blue cathode
buffer and load 50 μg of mitochondrial proteins into each lane. Fill the inner
chamber with the blue cathode buffer (Thermo fisher) and the outer chamber with
the native running buffer (Thermo fisher). Protein complexes were separated by
electrophoresis for 30 min at 150 V. After changing the buffer in the inner chamber
to light blue buffer, run for another 60 min at 250 V. Resolved protein complexes
were transferred to a PVDF membrane using the high molecular protein default
program on a Trans-Blot Turbo Transfer System (Bio-Rad). The membrane was
fixed in 8% acetic acid and destained in methanol. The membrane was blocked and
probed for proteins of interest as described in the immunoblotting section.
In the 2nd dimension BN-SDS-PAGE analysis, gel stripes of BN-PAGE gel were
excised and incubated in 1X laemmli sample buffer and incubated at 95 °C briefly.
The gel stripe was horizontally inserted into a SDS-PAGE gel in which gel fingers
were removed. The rightmost gel finger was kept for the purpose of loading a SDS
treated control sample. Proteins were resolved by SDS-PAGE and analyzed by
immunoblotting as described above.
Sodium carbonate extraction. Sodium carbonate extraction was performed as
described with minor modifications78. Mitochondria pellets isolated from
HEK293T cells were resuspended in buffer C (320mM Sucrose, 1 mM EDTA,
10 mM Tris-Cl pH 7.4), buffer C containing 1% Triton X or 0.1M Na2CO3 pH 11.
The resuspensions were incubated at 4 °C for 1 h with gentle nutation. Supernatant
and insoluble pellet were separated by centrifugation at 20,000 × g for 30 min, and
the supernatant was gently removed without disturbing the pellet. Equal fractions
of supernatant and pellet were analyzed by SDS-PAGE immunoblotting.
Mitochondrial membrane fractionation. Mitochondria were isolated with iso-
tonic buffer (250 mM sucrose, 1 mM EDTA, 10 mM HEPES-KOH pH 7.4, protease
inhibitor cocktail and 1 mM PMSF) from HEK293T cells following procedures
described in the mitochondria isolation section. Mitochondria pellet was gently
resuspended in the isotonic buffer to get protein concentration at 1 mg/mL. Ali-
quots of mitochondria were solubilized by increasing concentrations of digitonin
(0%, 0.1%, 0.115%, 0.13%, 0.145%, 0.16%, 0.175%, 0.19%, 0.205%, and 0.22%) for
1 h at 4 °C. Soluble and insoluble fractions were separated by centrifugation at
20,000 × g for 20 min Insoluble fractions were fully resuspended in an equal
amount of isotonic buffer to match the volume of supernatant. Both fractions were
lysed in 1X laemmli sample buffer and analyzed by SDS-PAGE and
immunoblotting.
Protease sensitivity assay. Mitochondria were isolated with isotonic buffer
(250 mM sucrose, 1mM EDTA, 10 mM HEPES-KOH pH7.4, protease inhibitor
cocktail) from HEK293T cells. Mitochondria pellet was washed to eliminate pro-
tease inhibitors. Mitochondria were resuspended to a protein concentration of
1 mg/mL. Mitochondrial membranes were by differentially solubilized by
increasing concentrations of digitonin (0–0.2% as indicated in the figure) or 1%
Triton X for 10 min on ice. Proteinase K was then added to 100 μg/mL and
incubated for 30 min on ice to allow the complete digestion of accessible proteins.
To terminate the protease digestion, PMSF was freshly prepared and added to a
concentration of 8 mM. Samples were analyzed by western.
Mass spectrometry analysis of isolated mitochondria. Crude mitochondrial
protein isolated from adult zebrafish skeletal muscle or MEF was normalized using
the Pierce Protein Assay Kit (ThermoFisher Scientific). Mitochondrial protein was
solubilized in 1% (w/v) SDC, 100mM Tris pH 8.1, 40 mM chloroacetamide (Sigma)
and 10 mM tris(2-carboxyethyl)phosphine hydrochloride (TCEP; BondBreaker,
ThermoFisher Scientific) for 5 min at 99 °C with 1500 rpm shaking followed by
15 min sonication in a water bath sonicator. Protein digestion was performed using
trypsin (ThermoFisher Scientific) at a 1:50 trypsin:protein ratio at 37 °C overnight.
The supernatant was transferred to Stagetips made in-house containing 3x14G
plugs of 3M™Empore™ SDB-RPS substrate (Sigma) as described previously61,79 with
modifications. Briefly, isopropanol (99% v/v) containing 1% (v/v) TFA was added
to the tip and mixed with the lysate prior to centrifugation at 3000 × g. Stagetips
were then washed first with the same solution followed by an additional wash
with 0.2% (v/v) TFA. Peptides were eluted in 80 % (v/v) acetonitrile (ACN) and 1%
(w/v) NH4OH, and then acidified to a final concentration of 1% TFA prior to
drying in a CentriVap Benchtop Vacuum Concentrator (Labconco). Peptides
reconstituted in 0.1% TFA were desalted on Pierce C-18 tips (Thermo Scientific) as
per manufacturer’s instructions prior to drying under vacuum. Desalted peptides
were reconstituted in 100mM triethylammonium bicarbonate (TEAB, Thermo-
Fisher Scientific) and labeled with 6plex Tandem Mass Tags (TMT) (ThermoFisher
Scientific) in 8:1 label:protein ratio as per manufacturer instructions. Labels were
pooled such that each multiplex set contained three replicates each of Br KO and
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control mitochondria. Pooled samples were fractionated using the Pierce High pH
Reversed-Phase Peptide Fractionation Kit (ThermoFisher Scientific) as per man-
ufacturer’s instructions for a TMT experiment. Individual fractions were dried
under vacuum and reconstituted in 2% (v/v) acetonitrile (ACN) and 0.1% (v/v)
trifluoroacetic acid (TFA).
Liquid chromatography (LC) coupled MS/MS was carried out on an Orbitrap
Lumos mass spectrometer (ThermoFisher Scientific) with a nanoESI interface
coupled to an Ultimate 3000 RSLC nanoHPLC (Dionex Ultimate 3000). The LC
system was equipped with an Acclaim Pepmap nano-trap column (Dionex-C18,
100, 75 μm× 2 cm) and an Acclaim Pepmap RSLC analytical column (Dionex-C18,
100., 75 μm× 50 cm). The tryptic peptides were injected to the trap column at an
isocratic flow of 5 μL/min of 2% (v/v) ACN containing 0.1% (v/v) formic acid for 5
min applied before the trap column was switched in-line with the analytical
column. Peptides were eluted using 5% DMSO in 0.1% v/v formic acid (solvent A)
and 5% DMSO in 100% v/v ACN and 0.1% v/v formic acid (solvent B) using a
custom 128-minute non-linear gradient that included a step for equilibration of the
column prior to injection of the next sample. The Synchronous Precursor Selection
(SPS)–MS3 based TMT method was used. In brief, a full MS1 spectra was acquired
in positive mode at 120,000 resolution scanning from 380–1500 m/z. AGC target
was at 4e5 and maximum injection time of 50 ms. Precursors for MS2/MS3 analysis
were selected based on a Top 3 second method. MS2 analysis consists of collision
induced dissociation (CID) with isolation window of 0.7 in the quadrupole. CID
was carried out with normalized collision energy of 35 and activation time of 10 ms
with detection in the ion trap. Following acquisition of each MS2 spectrum,
multiple MS2 fragment ions were captured in the MS3 precursor population using
isolation waveforms frequency notches. The MS3 precursors were fragmented by
high-energy collision-induced dissociation (HCD) and analyzed using the Orbitrap
with scan range of 100–500 m/z, 60,000 resolution, normalized collision energy of
60%, AGC target of 1e5 and maximum injection time of 120 ms.
Raw files were processed using the MaxQuant platform (version 1.6.10.43)80
and searched against UniProt zebrafish reviewed and unreviewed or mouse
reviewed database containing canonical and isoform sequences (November 2019)
using default settings for a TMT 6plex experiment. The proteinGroups.txt output
was processed in Perseus (version 1.6.10.43)81. Briefly, Log2-transformed TMT
reporter intensity corrected values were grouped into control and KO groups
consisting of three replicates each. Values were normalized by subtraction of the
median value in each column and identifications filtered to include 100% valid
values across all six samples and quantifications being made from more than 2
unique peptides. Zebrafish Uniprot identifiers were first matched to human
orthologs using a database generated from the Zebrafish Information Network
(ZFIN) database82. Zebrafish and mouse mitochondrial proteins were annotated
based on the presence of their human ortholog or mouse gene symbol being
present in either of the Mitocarta2.016 or Integrated Mitochondrial Protein Index
(IMPI)83 databases. The datasets were re-normalized for variance introduced by
mitochondrial isolation through subtraction of the mean value of proteins with
mitochondrial proteins using the subtract row cluster function in Perseus.
For volcano plots, a two-sided t-test was performed between KO and control
groups with significance determined by Student’s t-test (p-value<0.05, unpaired t-
test). For clustering and mapping of data to Cryo-EM structures, median values for
each experimental group were determined along with the intragroup standard
deviation. Thresholds were determined for filtering highly variant medians based
on the distrubtion of standard deviations (for the zebrafish dataset values <2 stdev
were considered significant, for the mouse dataset only values <0.6 were retained).
Ratios were determined for each protein (KO/control) and used for hierarchical
clustering and structure mapping. For hierarchical clustering, protein ratios were
subsetted based on their human orthologs presence in the indicated RC complexes.
Euclidian distances (average linkage) were used for k-means clustering of rows and
columns. For structural mapping, protein ratios for the same RC subunits were
mapped onto the relevant chains of following PDB structures using a custom
python script described previously61; Complex I, 5LDW84; Complex II, 1ZOY;85
Complex III, 1BGY86; and Complex IV, 5B1A87. In the case of multiple isoforms
present for some RC subunits in the zebrafish dataset, the most altered protein was
used for the structure mapping.
BR interactome analysis. To determine physical interaction partners of BRAW-
NIN (BR), we purified BR (non-tagged and FLAG tag) with different antibodies at
different expression levels (endogenous and over-expressed). To purify endogenous
BR, mitochondria were isolated from HEK293T cells as described. Mitochondria
were solubilized in 1 mL of IP buffer (150 mM NaCl, 1 mM EDTA, 50 mM HEPES-
KOH pH 7.4) containing 1% n-Dodecyl β-D-maltoside (DDM), cOmplete, EDTA-
free protease inhibitor cocktail (Roche) and 1 mM PMSF at 4 °C for 30 min with
constant rocking. Homogenate was spun at 20,000 × g for 10 min at 4 °C to remove
insoluble content and the supernatant was collected and incubated with BR anti-
body (Novus, NBP1-90536) or Rabbit IgG control for overnight. In all, 30 μl of
protein A/G beads were washed with IP buffer containing 0.1% DDM for two times
and incubated with the protein lysate for 2 h at 4 °C to allow antibody/protein
complex binding. Non-interacting proteins were removed by four rounds of spin
and IP buffer washes in the presence of 0.5% DDM. The beads were then washed
with IP buffer only. Bound proteins were eluted with 0.1% Rapigest at room
temperature. For the isolation of over-expressed BR, a similar workflow was
performed except that BR was transiently over-expressed in HEK293T before the
sample preparation. For isolating FLAG tagged BR, we fused a single FLAG tag to
the c-terminus of BR. BR and BR-FLAG were transiently overexpressed in
HEK293T. Mitochondria were isolated from the two samples separately and
solubilized with IP buffer (150 mM NaCl, 1 mM EDTA, 50 mM HEPES-KOH pH
7.4) containing 1% n-Dodecyl β-D-maltoside (DDM), cOmplete, EDTA-free pro-
tease inhibitor cocktail (Roche) and 1 mM PMSF. After clearing the insoluble
fraction by spin, protein lysates were incubated with anti-FLAG M2 resin (Sigma)
for overnight with nutation. The resin was washed as described above and eluted
with 0.1% Rapigest (Waters).
To prepare for mass spectrometry, samples were treated with 100mM
triethylammonium bicarbonate (TEAB) pH 8.5 and 20mM tris(2-carboxyethyl)
phosphine hydrochloride TCEP for 20min at 55 °C with shaking. Proteins were then
alkylated by 55mM chloroacetamide (CAA) at room temperature for 30min in dark.
In total, 3 volumes of 100mM TEAB were added to dilute out Rapigest to allow
following protease digestion. The sample was first treated by 2.5 μg of LysC (Wako)
for 3 h at 37 °C with shaking and then treated with 2.5 μg of Trypsin (Promega) for
over-night at 37 °C with shaking. Rapigest was hydrolyzed by adding TFA to 1% and
removed by spin at 20, 000 g for 10min The sample was desalted on a C18 cartridge
(Oasis) and eluted with 50% ACN and 100mM TEAB pH8.5, vacuum concentrated
and resuspend in 100mM TEAB pH 8.5. Peptides were labeled with 10 plex tandem
mass tags (TMT) for over-night and then quenched by 0.5M Tris-HCl pH7.4,
pooled, desalted again and analyzed by an Orbitrap LC/MS88.
Mouse housing conditions. In this study, C57BL6/J mice were housed on a 12-h
light/dark cycle with water and normal chow diet provided ad libitum. Room
temperature was maintained at 21–24 °C and relative humidity at 40–60%. All
animal procedures were approved and conducted in accordance with the Duke-
NUS, SingHealth Institutional Animal Care and Use Committee.
BR co-IP with complex III. To express FLAG tagged BR from mouse tissue, BR
Adeno-associated Virus (AAV) expression construct was generated by inserting the
murine BR ORF into a pscAAV2 backbone with a single FLAG peptide fused to the
c-terminus of BR. AAV9-pseudotyped virus was produced by Vector Core, Gen-
ome Institute of Singapore, Singapore. In all, 109 viral genomes were constituted in
10 μL PBS and administrated to the gastrocnemius muscle of 1-month-old female
animals. Skeletal muscles were isolated 1–2 months after the AAV administration.
Mitochondria were isolated from tissues as described above and solubilized with
1% digitonin (digitonin: mitochondria protein ratio was normalized to 4 g/g.) in IP
buffer (150 mM NaCl, 1 mM EDTA, 50 mM HEPES-KOH pH 7.4) containing
cOmplete, EDTA-free protease inhibitor cocktail (Roche) and 1 mM PMSF at 4 °C
for 30 min with constant rocking. The insoluble fraction was removed by cen-
trifugation at 20,000 × g for 15 min. The supernatant was incubated with 30 μl of
anti-FLAG M2 resin and nutated for over-night in a cold room. The resin was
extensively washed with IP buffer supplemented with 0.1% digitonin for four times.
BR-FLAG and its interaction partners were eluted with 0.5 mg/mL 3XFLAG
peptide (Sigma) in IP buffer at 4 °C for 30 min IP input and elute were analyzed by
SDS-PAGE. In the reciprocal IP, mitochondria were isolated from HEK293T cells
transiently expressing UQCRQ-FLAG and BR-HA. Protein IP was described
as above.
Cell culture. All cell lines were obtained from American Type Cell Collection
(ATCC; www.atcc.org) and cultured using standard tissue culture techniques.
HEK293T (ATCC® CRL-3216™) cells were cultured in Dulbecco’s High Glucose
Modified Eagles Medium/High Glucose (HyClone). U87MG (ATCC® HTB-14™)
cells were cultured in Minimal Essential Medium with L-Glutamine (Gibco). All
media were supplemented with 10% South American sourced Fetal Bovine Serum
(HyClone) and 1% of 10,000 U/mL of Penicillin-Streptomycin (Gibco). Starvation
regimes were performed as follows: HEK293T cells were plated in normal DMEM
(4500 mg/L glucose) overnight, followed by a complete media change to that
containing 3 μM Etomoxir in complete media, media lacking FBS (Serum-) and or
DMEM without glucose (GLUCOSE-).
MEF generation. Br KO were generated by Crispr/Cas9-mediated targeting of the
mouse 1190007I07Rik gene followed by MEF derivation from F1 embryos. Briefly, a
pair of guide RNAs (gRNAs : 5′-cctcctggccatgtgcgccg-3′, 5′-gaactcaaaacggagctttt-3′)
along with recombinant Cas9 protein were introduced by pronuclear injection into
C57BL6 fertilized oocytes. Successful excision of exons 2 and 3 containing the
coding region was verified by genomic PCR. Heterozygous F1 mice were inter-
crossed and embryos were harvested at E13.5 after CO2 euthanasia. Uterine horns
were dissected out and rinsed with cold DPBS (Hyclone) with 2% of 10,000 U/mL
of Penicillin-Streptomycin (Gibco). Upon releasing, head and viscera of embryos
were lysed for genotyping and discarded respectively. Remaining tissues were finely
minced with blades and digested with 0.25% Trypsin-EDTA (Gibco) at 37 °C for
30 min with gentle pipetting every 10 min Trypsin was then neutralized with an
equal amount of complete medium [Dulbecco’s High Glucose Modified Eagles
Medium/High Glucose (HyClone) supplemented with 10% FBS and 1% of 10,000
U/mL of Penicillin-Streptomycin (Gibco)]. Digested tissues were centrifuged at
1200 × g for 5 min at room temperature. Cell and tissue pellet resuspended and
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passed through a 70-μm cell strainer (BD). Cells were seeded to a 10-cm dish pre-
coated with gelatine and was cultured with complete medium. In sub-culturing,
MEFs were detached with 0.05% Trypsin-EDTA (Gibco).
BR over-expression by lentivirus transduction. The human BR ORF was
inserted into a pCDH lentivirus vector under the control of a CMV promoter.
Plasmid was then packaged into viral particles using the pPACKH1 lentivector
Packaging Kit (System Bioscience) in HEK293T cells. In all, 25% of total crude
virus extracted was used to infect U87MG for 2 days before G418 (Santa Cruz)
selection at 1.2 mg/mL.
Brawnin knockdown. siRNA-mediated knockdown of BR was performed in
U87MG with ON-TARGET plus Human C12orf73 (728568) siRNAs (Dharmacon)
with the following sequences: 5′-CAGUGGAUGUUUAGCCGAU-3′ (siBR_14)
and 5′-CGACCGGACCUGACAAUAC-3′ (siBR_16). An equimolar ratio of both
targeting siRNAs are mixed to achieve maximal knockdown. Control siRNA
sequence is 5′-UGGUUUACAUGUCGACUAA-3′. Briefly, siRNAs are transfected
at 25 nM final concentration using Dharmafect using a suspension transfection
protocol for U87MG.
shRNA-mediated knockdown or BR was performed using the following
sequences: 5′-AAAAGTTCGCGGTACAGTCTCTAGT-3′ (shBR_1) and 5′-
AAAAGTGGATGTTTAGCCGATACGT-3′ (shBR_3). shRNA hairpins were
cloned into a lentiviral backbone to allow stable expression. Viral particles were
produced in LentiX293 and purified according to standard procedures. 500,000
U87MG cells were collected and resuspended with respective medium with 32 μg/
mL of polybrene, and added to polybrene-treated cells at a target MOI of 3. Cell-
virus suspension solution was centrifuged at 1000 × g for 1 h at room temperature
to maximize the collision between cells and viruses. The mixture was then diluted
four times with respective medium and seeded to one 6-well plate (Costar).
Following recovery from viral transduction, cells were selected with 1 μg/mL of
puromycin until a non-transduced control showed complete death. U87MG Scr,
shBR cells were used within 10 passages of initial transduction to minimize
phenotypic drift due to compensation.
Seahorse cultured cell MitoStress test. In all, 15,000 U87MG cells were plated
on poly-L-Lysine (Sigma) treated Seahorse XF96 Cell Culture Microplates (Agilent)
and XFe96 sensor cartridge (Agilent) was hydrated with distilled water at 37 °C
with no CO2 the day prior to MitoStress Assay. On the day of actual MitoStress
Assay, cultured cells were washed once and media were replaced with XF basal
DMEM supplemented with 1 mM pyruvate (Sigma), 2 mM glutamine (Sigma), and
10 mM glucose (Sigma). Pre-hydrated sensor cartridge was calibrated with Sea-
horse XF Calibrant (Agilent). Both cell culture plate and sensor cartridge were
incubated at 37 °C with no CO2 for at least 45 min before actual assay starts. For
MitoStress assay, 2 μM of oligomycin (Sigma), 1 μM of FCCP (Sigma), and 1 μM of
Rotenone/Antimycin (Sigma/Sigma) were injected according to Seahorse MitoS-
tress Assay Protocol (Agilent). MitoStress test data were obtained using XF96
Seahorse Wave software, Agilent. Citrate Synthase Normalization Assay was per-
formed on the cultured cell plate to normalize the measured Oxygen Consumption
Rate (OCR) and ExtraCellular Acidification Rate (ECAR).
Citrate Synthase Normalization Assay. Citrate Synthase Normalization Assay
was performed on Seahorse XF96 Cell Culture Microplate (Agilent) right after
seahorse assay or on plates frozen at −80 °C with leftover medium aspirated. All
leftover medium was removed and replaced with 113 μL of CS buffer (200 mM Tris
buffer at pH8.0, 0.2% Triton X-100 (v/v), 100 μM DTNB (Sigma) in 100 mM Tris
buffer at pH8.0, 1mM Acetyl-CoA (Sigma)) per well. In all, 5 μL of 10mM Oxa-
loacetate (Sigma) in water was added to each well as reaction substrate. Absorbance
at 412 nM at 37 °C was recorded with Tecan Microplate Reader M200 (Tecan) at
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n is the total number of absorbance records; A is the absorbance recorded; t is
the time.
Respiratory chain enzymatic assays. Respiratory chain enzymatic assays were
performed with zebrafish skeletal muscle homogenates according to the protocol as
described by Spinazzi et al.35.
Statistics and reproducibility. Unless otherwise stated, all data are presented
as Mean ± standard error of mean (SEM.). Statistical approaches to test differences
of means were performed using Prism 5.0. The statistical test used in each
panel is indicated in each accompanying figure legend. Where p-values are not
explicitly indicated, significance levels follow the convention of *p < 0.05, **p < 0.01,
***p < 0.001.
The reproducibility of representative data is as follows: Experiments of Figs. 1e,
2e, f, i–k, 3b, 4a, 5f, and 6f, Supplementary Figs. 1e, 2d, e, g–k, 4b, d, and 6f, h–k
were repeated independently for two times with similar data obtained in all
replicates. Experiments of Figs. 2c, d, g, h, l, m, 3c, 4b, and 5e, Supplementary
Figs. 2f, 3e, and 6a, e were repeated independently for three times with similar
data obtained in all replicates. Experiments of Fig. 4e, Supplementary Figs. 4a
and 6b were repeated independently for more than three times with similar data
obtained in all replicates.
Reporting summary. Further information on research design is available in
the Nature Research Reporting Summary linked to this article.
Data availability
Proteomics data are available from Proteome Xchange. Accession: PXD016718, Source
data for all western blots shown are available as a manuscript supplement,10.6084/m9.
figshare.11406999, [https://figshare.com/s/76fbb5bf11af6d5d01af]. All reagents cited,
including animals, will be available upon request through MTA.
Weblinks of publicly available datasets that used in the study: [http://www.sorfs.org/]
Skeletal muscle dataset for GSEA: [https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?
acc=GSE120862] Skin data for GSEA:
[https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE85861] Liver dataset for
GSEA: [https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE94660] Heart dataset
for GSEA: [https://www.ebi.ac.uk/ega/studies/EGAS00001002454]
Code availability
All R code for WCGNA/GSEA analyses are available from [https://github.com/
LenaHoLab/Zhang-et-al-manuscript-R-code].
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